Concepedia

Helmut Oettle

HO

87

Publications

11.3K

Citations

47

H-Index

1992

Active since

Affiliations

Charité - Universitätsmedizin Berlin(Current)

Humboldt-Universität zu Berlin

Goethe University Frankfurt

Freie Universität Berlin

Dermatopathologie Friedrichshafen

Helmut Oettle is an author at Charité - Universitätsmedizin Berlin specializing in medicine, oncology, and cancer research.

Top concepts

Publications per year

1992–2025

87

Publications

87

Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer

Helmut Oettle, Stefan Post, P. Neuhaus et al. · JAMA · 2007 · 2.4K citations

Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer

Helmut Oettle, P. Neuhaus, Andreas Hochhaus et al. · JAMA · 2013 · 1.8K citations

Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer

Eric Van Cutsem, Helgi van de Velde, Petr Karásek et al. · Journal of Clinical Oncology · 2004 · 772 citations · Full text

Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial

Helmut Oettle, Hanno Riess, Jens Stieler et al. · Journal of Clinical Oncology · 2014 · 476 citations

Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study group

Uwe Pelzer, Ingo Schwaner, Jens Stieler et al. · European Journal of Cancer · 2011 · 379 citations

, , +7

Rows per page

1–5 of 87